3-hydroxyglutaric acid induces oxidative stress and decreases the antioxidant defenses in cerebral cortex of young rats

Brain Research

Volumn 956, Issue 2, 2002, Pages 367-373

  Latini, Alexandra ^a   Borba Rosa, Rafael ^a   Scussiato, Karina ^a   Llesuy, Susana ^a   Belló Klein, Adriane ^a   Wajner, Moacir ^a  

^a FEDERAL UNIVERSITY OF RIO GRANDE DO SUL   (Brazil)

Author keywords

3 Hydroxyglutaric acid; Free radical; Glutaric aciduria type I; Glutaryl CoA dehydrogenase deficiency; Lipoperoxidation; Nitric oxide; Oxidative stress

Indexed keywords

3 HYDROXYGLUTARIC ACID; GLUTARIC ACID DERIVATIVE; GLUTARYL COENZYME A DEHYDROGENASE; NITRIC OXIDE; THIOBARBITURIC ACID REACTIVE SUBSTANCE; UNCLASSIFIED DRUG;

ANIMAL TISSUE; ARTICLE; BRAIN CORTEX; CHEMOLUMINESCENCE; CONTROLLED STUDY; ENZYME DEFICIENCY; LIPID PEROXIDATION; MALE; METABOLITE; NONHUMAN; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN DETERMINATION; RAT;

ANIMALS; ANTIOXIDANTS; CEREBRAL CORTEX; CHEMILUMINESCENT MEASUREMENTS; GLUTARATES; MALE; NITRIC OXIDE; OXIDATIVE STRESS; RATS; RATS, WISTAR; THIOBARBITURIC ACID REACTIVE SUBSTANCES;

EID: 0037195559     PISSN: 00068993     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-8993(02)03573-4     Document Type: Article

References (37)

1. Almeida A., Heales S.J.R., Bolaños J.P., Medina J.M. Glutamate neurotoxicity is associated with nitric oxide-mediated mitochondrial dysfunction and glutathione depletion. Brain Res. Rev. 790:1998;209-216.
2. Beal M.F. Aging, energy, and oxidative stress in neurodegenerative diseases. Ann. Neurol. 38:1995;357-366.
3. Beal M.F. Mitochondria, free radicals, and neurodegeneration. Curr. Opin. Neurobiol. 6:1996;661-666.
4. Bolaños J.P., Almeida A., Medina J.M. Nitric oxide mediates brain mitochondrial damage during perinatal anoxia. Brain Res. 787:1998;117-122.
5. Bolaños J.P., Almeida A., Stewart V., Peuchen S., Land J.M., Clark J.B., Heales S.J.R. Nitric oxide-mediated mitochondrial damage in brain: mechanisms and implications for neurodegenerative diseases. J. Neurochem. 68:1997;2227-2240.
6. Brismar J., Ozand P.T. CT, MR of the brain in glutaric acidemia type I: a review of 59 published cases and a report of 5 new patients. Am. J. Neuroradiol. 16:1995;675-683.
7. Chow C.W., Haan E.A., Goodman S.I., Anderson R.M., Evans W.A., Kleinschmidt-DeMasters B.K., Wise G., McGill J.J., Danks D.M. Neuropathology in glutaric acidaemia type 1. Acta Neuropathol. 76:1988;590-594.
8. 2+/calmodulin kinase inhibitor KN93. J. Neurochem. 70:1998;1898-1906.
9. de Mello C.F., Kölker S., Ahlemeyer B., de Souza F.R., Fighera M.R., Mayatepek E., Krieglstein J., Hoffmann G.F., Wajner M. Intrastriatal administration of 3-hydroxyglutaric acid induces convulsions and striatal lesions in rats. Brain Res. 916:2001;70-75.
10. Esterbauer H., Cheeseman K.H. Determination of aldehydic lipid peroxidation products: malonaldehyde and 4-hydroxynonenal. Methods Enzymol. 186:1990;407-421.
11. Forstner R., Hoffmann G.F., Gassner I., Heideman P., de Klerk J.B., Lawrenz-Wolf B., Doringer E., Weiss-Wichert P., Troger J., Colombo J.P., Plochl E. Glutaric aciduria type I: ultrasonographic demonstration of early signs. Pediatr. Radiol. 29:1999;138-143.
12. Gonzalez-Flecha B., Llesuy S., Boveris A. Hydroperoxide-initiated chemiluminescence: an assay for oxidative stress in biopsies of heart, liver and muscle. Free Rad. Biol. Med. 10:1991;93-100.
13. Goodman S.I., Norenberg M.D., Shikes R.H., Breslich D.J., Moe P.G. Glutaric aciduria type 1: biochemical and morphological considerations. J. Pediatr. 90:1977;746-750.
14. Goodman S.I., Frerman F.E. Organic acidemias due to defects in lysine oxidation: 2-ketoadipic academia and glutaric acidemia. Scriver C.R., Beaudet A.L., Sly W.S., Walle D., The Metabolic and Molecular Bases of Inherited Disease. 8th Edition:2001;2195-2204 McGraw-Hill, New York.
15. Halliweel B. Free radicals, proteins and DNA: oxidative damage versus redox regulation. Biochem. Soc. Trans. 24:1996;1023-1027.
16. Halliwell B., Gutteridge J.M.C. Oxygen radicals and nervous system. Trends Neurosci. 8:1996;22-26.
17. Halliwell B., Gutteridge J.M.C. Oxygen is a toxic gas - an introduction to oxygen toxicity and reactive oxygen species. Halliwell B., Gutteridge J.M.C., Free Radicals in Biology and Medicine. 3rd Edition:2001;1-35 Oxford University Press, Oxford.
18. Halliwell B., Gutteridge J.M.C. Detection of free radicals and others reactive species: trapping and fingerprinting. Halliwell B., Gutteridge J.M.C., Free Radicals in Biology and Medicine. 3rd Edition:2001;351-425 Oxford University Press, Oxford.
19. Hevel J.M., Marletta M.A. Nitric oxide synthase assays. Methods Enzymol. 233:1994;250-258.
20. Heyes M.P. Hypothesis: a role for quinolinic acid in the neuropathology of glutaric aciduria type I. Can. J. Neurol. Sci. 14:1987;441-443.
21. Hoffmann G.F., Zschocke J. Glutaric aciduria type I: From clinical, biochemical and molecular diversity to successful therapy. J. Inherit. Metab. Dis. 22:1999;381-391.
22. Hoffmann G.F., Athanassopoulos S., Burlina A.B., Duran M., de Klerk J.B., Lehnert W., Leonard J.V., Monavari A.A., Muller E., Muntau A.C., Naughten E.R., Plecko-Starting B., Superti-Furga A., Zschocke J., Christensen E. Clinical course, early diagnosis, treatment, and prevention of disease in glutaryl-CoA dehydrogenase deficiency. Neuropediatrics. 27:1996;115-123.
23. Karelson E., Bogdanovic N., Garlind A., Winblad B., Zilmer K., Kullisaar T., Vihalemm T., Kairane C., Zilmer M. The cerebrocortical areas in normal brain aging and in the Alzheimer's Disease: noticeable difference in the lipid peroxidation level and in antioxidant defense. Neurochem. Res. 26:2001;353-361.
24. Kölker S., Ahlemeyer B., Kriegstein J., Hoffmann G.F. 3-Hydroxyglutaric and glutaric acids are neurotoxic trough NMDA receptors in vitro. J. Inherit. Metab. Dis. 22:1999;259-262.
25. Kölker S., Okun J.G., Ahlemeyer B., Wyse A.T., Horster F., Wajner M., Kohlmuller D., Mayatepek E., Krieglstein J., Hoffmann G.F. Chronic treatment with glutaric acid induces partial tolerance to excitotoxicity in neuronal cultures from chick embryo telencephalons. J. Neurosci. Res. 685:2002;424-431.
26. Kölker S., Ahlemeyer B., Huhne R., Mayatepek E., Kriegstein J., Hoffmann G.F. Potenciation of 3-hydroxyglutarate neurotoxicity following induction of astrocitic iNOS in neonatal rat hippocampal cultures. Eur. J. Neurosci. 13:2001;2115-2122.
27. Kölker S., Ahlemeyer B., Kriegstein J., Hoffmann G.F. Contribution of reactive oxygen species to 3-hydroxyglutarate neurotoxicity in primary neuronal cultures from chick embryo telencephalons. Pediatr. Res. 50:2001;76-82.
28. Kölker S., Ahlemeyer B., Kriegsteinm J., Hoffmann G.F. Maturation-dependent neurotoxicity of 3-hydroxyglutaric and glutaric acids in vitro: a new pathophysiologic approach to glutaryl-CoA dehydrogenase. Pediat. Res. 47:2000;495-503.
29. Lissi E., Pascual C., Del Castillo M.D. Luminol luminescence induced by 2,2′-azo-bis-(2-amidinopropane) thermolysis. Free Rad. Res. Commun. 17:1992;299-311.
30. Llesuy S.F., Milei J., Molina H., Boveris A., Milei S. Comparison of lipid peroxidation and myocardial damage induced by adriamycin and 4′-epiadriamycin in mice. Tumori. 71:1985;241-249.
31. Lowry O.H., Rosebrough N.J., Lewis-Farr A., Randall R.J. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:1951;265-275.
32. Méndez-Álvarez E., Soto-Otero R., Hermida-Aeijeiras A., López-Real A.M., Labandeira-García J.L. Effects of aluminium and zinc on the oxidative stress caused by 6-hydroxydopamine autoxidation: relevance for the pathogenesis of Parkinson's disease. Biochim. Biophys. Acta. 1586:2001;155-168.
33. Nicholls D.G., Budd S.L. Mitochondria and neuronal glutamate excitotoxicity. Biochim. Biophys. Acta. 1366:1998;97-112.
34. Reznick A.Z., Packer L. Free radicals and antioxidants in muscular neurological diseases and disorders. Poli G., Albano E., Dianzani M.U., Free Radicals: From Basic Science To Medicine. 1993;425-437 Birkhäuser Verlag, Basel.
35. Stokke O., Goodman S.I., Moe P.G. Inhibition of brain glutamate decarboxylase by glutarate, glutaconate and beta-hydroxyglutarate: explanations of the symptoms in glutaric aciduria? Clin. Chim. Acta. 66:1976;411-415.
36. Ullrich K., Flott-Rahmel B., Schluff P., Musshoff U., Das A., Lücke T., Steinfeld R., Christensen E., Jacobs C., Ludolph A., Neu A., Röper R. Glutaric aciduria type I: pathomechanisms of neurodegeneration. J. Inherit. Metab. Dis. 22:1999;392-403.
37. 2+ block at the N-methyl-D-aspartate receptor underlies receptor activation during inhibition of neuronal metabolism. J. Neurochem. 59:1992;1211-1220.